GLP-1 drugs: what Maryland Medicaid paid

Maryland Medicaid shows a published payment figure for 6 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Maryland Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Maryland Medicaid’s payment record shows

In 2026Q1, the product Maryland Medicaid paid for most often was Ozempic®, at 27,326 prescriptions¹⁹ of the 38,244 to 38,559^{1,7,13,19,25,43} across all 8 products, or 72 percent of the published count.

Maryland Medicaid itself reimbursed at least $38,022,425 for these products in the quarter, about $995 per prescription. Pharmacies were paid $38,374,014 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,285.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Maryland Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Maryland Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Maryland Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Maryland Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Both	at least 1,561¹	4%	$1,619,653	$1,623,760	$1,038
tirzepatideMounjaro®	Both6,286 managed care, 167 direct	at least 6,453⁷	17%	$7,043,685	$7,131,779	$1,092
semaglutideWegovy®	Both448 managed care, 11 direct	at least 459¹³	1%	$589,657	$594,635	$1,285
semaglutideOzempic®	Both26,401 managed care, 925 direct	at least 27,326¹⁹	72%	$27,016,931	$27,261,766	$989
semaglutideRybelsus®	Both1,613 managed care, 19 direct	at least 1,632²⁵	4%	$1,614,566	$1,622,793	$989
liraglutideSaxenda®	Managed care	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both	Withheld	n/a	Not published	Not published	Not published
liraglutideliraglutide (generic)	Both758 managed care, 20 direct	at least 778⁴³	2%	$137,933	$139,282	$177

Maryland Medicaid publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Against enrollment, that is 31.8 to 32.0 prescriptions per thousand people enrolled in Maryland Medicaid, on an average of 1,203,259 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 19 of the 168 product-quarters it holds a row for here, which is 11 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic® and Rybelsus® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Maryland Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Maryland Medicaid paid for each product, quarter by quarter

Prescriptions Maryland Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable³Withheld4 of 4 product codes withheld	at least 18 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³At least$19,577 paid	at least 17 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³At least$14,483 paid	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	at least 18 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$18,643 paid	at least 272 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$283,380 paid	at least 584 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$603,541 paid	at least 1,035 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$1,063,146 paid	at least 1,561 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$1,619,653 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹¹Withheld1 of 1 product codes withheld	at least 71 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$66,413 paid	at least 305 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$284,355 paid	at least 588 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$579,140 paid	at least 808 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$780,960 paid	at least 1,011 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$959,645 paid	at least 1,313 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$1,279,370 paid	at least 2,044 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$2,205,502 paid	at least 2,580 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$2,807,147 paid	at least 3,209 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$3,463,325 paid	at least 3,630 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$3,933,467 paid	at least 3,742 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$3,855,773 paid	at least 4,576 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$4,768,419 paid	at least 4,825 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$5,083,626 paid	at least 5,303 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$5,609,833 paid	at least 6,453 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$7,043,685 paid
semaglutideWegovy®range 196 to 273	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable¹⁶Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable¹⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable¹⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable¹⁶Withheld2 of 2 product codes withheld	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter¹⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable¹⁵Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable¹⁵Withheld3 of 3 product codes withheld	at least 169 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$217,339 paid	196 paid prescriptions in the quarter (2025Q1)¹⁴Count$250,078 paid	273 paid prescriptions in the quarter (2025Q2)¹⁴Count$350,277 paid	at least 302 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld¹⁴At least$383,072 paid	at least 369 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$469,855 paid	at least 459 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$589,657 paid
semaglutideOzempic®	at least 5,265 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$4,569,260 paid	at least 5,997 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$5,242,881 paid	at least 6,718 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$5,847,557 paid	at least 7,335 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$6,376,829 paid	at least 8,282 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$7,529,171 paid	at least 9,443 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$8,651,674 paid	at least 10,601 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$9,596,586 paid	at least 11,585 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$10,436,572 paid	at least 13,664 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$12,681,018 paid	at least 16,550 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$15,092,925 paid	at least 16,036 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$14,661,595 paid	at least 13,081 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$12,109,371 paid	at least 15,417 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$14,456,760 paid	at least 18,822 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$17,779,736 paid	at least 20,225 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$19,117,076 paid	at least 20,393 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$19,235,487 paid	at least 20,177 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$19,144,684 paid	at least 25,487 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$24,326,774 paid	at least 27,567 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$26,348,156 paid	at least 28,035 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$26,819,676 paid	at least 27,326 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$27,016,931 paid
semaglutideRybelsus®	at least 169 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$136,636 paid	at least 295 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$250,396 paid	at least 471 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$410,510 paid	at least 603 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$529,471 paid	at least 710 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$649,818 paid	at least 903 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$831,529 paid	at least 1,040 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$939,287 paid	at least 1,265 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$1,181,928 paid	at least 1,468 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$1,397,457 paid	at least 1,651 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$1,588,416 paid	at least 1,529 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$1,470,491 paid	at least 1,807 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$1,775,660 paid	at least 2,157 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$2,078,577 paid	at least 2,383 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$2,299,845 paid	at least 2,360 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$2,253,758 paid	at least 2,181 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$2,050,081 paid	at least 1,969 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$1,874,861 paid	at least 1,885 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$1,799,356 paid	at least 1,863 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$1,772,937 paid	at least 1,748 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$1,672,008 paid	at least 1,632 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$1,614,566 paid
liraglutideSaxenda®range 14 to 30	14 paid prescriptions in the quarter (2021Q1)³⁶Count$18,248 paid	19 paid prescriptions in the quarter (2021Q2)³⁶Count$23,262 paid	30 paid prescriptions in the quarter (2021Q3)³⁶Count$37,766 paid	20 paid prescriptions in the quarter (2021Q4)³⁶Count$24,630 paid	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³¹Withheld1 of 1 product codes withheld
liraglutideVictoza®range 488 to 1,940	1,940 paid prescriptions in the quarter (2021Q1)⁴²Count$1,750,050 paid	1,781 paid prescriptions in the quarter (2021Q2)⁴²Count$1,621,377 paid	1,635 paid prescriptions in the quarter (2021Q3)⁴²Count$1,462,907 paid	1,401 paid prescriptions in the quarter (2021Q4)⁴²Count$1,248,278 paid	1,214 paid prescriptions in the quarter (2022Q1)⁴¹Count$1,167,723 paid	1,096 paid prescriptions in the quarter (2022Q2)⁴¹Count$1,049,845 paid	1,046 paid prescriptions in the quarter (2022Q3)⁴¹Count$987,405 paid	962 paid prescriptions in the quarter (2022Q4)⁴¹Count$908,523 paid	1,009 paid prescriptions in the quarter (2023Q1)⁴⁰Count$954,406 paid	834 paid prescriptions in the quarter (2023Q2)⁴⁰Count$805,225 paid	at least 689 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld⁴⁰At least$648,749 paid	548 paid prescriptions in the quarter (2023Q4)⁴⁰Count$490,491 paid	488 paid prescriptions in the quarter (2024Q1)³⁹Count$339,024 paid	at least 439 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³⁹At least$308,653 paid	at least 130 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³⁹At least$85,138 paid	at least 28 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³⁹At least$19,029 paid	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³⁸No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³⁸No row	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³⁷Withheld1 of 1 product codes withheld
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable⁴⁵Withheld2 of 2 product codes withheld	at least 266 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$144,972 paid	at least 325 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$174,168 paid	at least 489 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$183,249 paid	at least 608 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$202,165 paid	at least 756 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$235,206 paid	at least 781 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$186,790 paid	at least 778 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$137,933 paid

What this page cannot tell you

Whether Maryland Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Maryland in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, MD
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state MD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MD", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND 2", "suppression_used": "false", "number_of_prescriptions": "413"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, MD
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state MD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND 2", "suppression_used": "false", "number_of_prescriptions": "309"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, MD
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state MD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2024", "quarter": "2", "utilization_type": "FFSU", "product_name": "ZEPBOUND 2", "suppression_used": "false", "number_of_prescriptions": "18"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, MD
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state MD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "product_name": "product_name like ZEPBOUND%, state MD, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, MD
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state MD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "product_name": "product_name like ZEPBOUND%, state MD, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, MD
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state MD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "product_name": "product_name like ZEPBOUND%, state MD, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, MD
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state MD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MD", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1502"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, MD
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state MD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1172"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, MD
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state MD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1022"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, MD
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state MD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "397"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, MD
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state MD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "128"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, MD
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state MD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "product_name": "product_name like MOUNJARO%, state MD, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, MD
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state MD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MD", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "100"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, MD
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state MD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 1 M", "suppression_used": "false", "number_of_prescriptions": "84"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, MD
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state MD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "108"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, MD
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state MD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.5", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, MD
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state MD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "product_name": "product_name like WEGOVY%, state MD, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, MD
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state MD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "product_name": "product_name like WEGOVY%, state MD, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, MD
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state MD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MD", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 2 ", "suppression_used": "false", "number_of_prescriptions": "9424"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, MD
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state MD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "9822"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, MD
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state MD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "7709"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, MD
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state MD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "6709"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, MD
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state MD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "5708"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, MD
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state MD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "4077"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, MD
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state MD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MD", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "780"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, MD
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state MD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "907"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, MD
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state MD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "1031"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, MD
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state MD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "768"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, MD
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state MD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "574"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, MD
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state MD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "242"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, MD
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state MD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MD", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, MD
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state MD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, MD
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state MD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, MD
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state MD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, MD
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state MD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2022", "quarter": "2", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, MD
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state MD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "false", "number_of_prescriptions": "30"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, MD
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state MD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MD", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, MD
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state MD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, MD
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state MD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "232"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, MD
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state MD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "560"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, MD
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state MD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "719"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, MD
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state MD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2021", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "1236"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, MD
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state MD, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "MD", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "235"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, MD
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state MD, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "302"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, MD
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state MD, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "175"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, MD
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state MD, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "product_name": "product_name like LIRAGLUTID%, state MD, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, MD
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state MD, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "product_name": "product_name like LIRAGLUTID%, state MD, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, MD
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state MD, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "MD", "product_name": "product_name like LIRAGLUTID%, state MD, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 39 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 9 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Maryland Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.